Johnson & Johnson Innovation – JJDC has co-led the computational pathology technology provider's series C round to take its total funding to $195m.

Paige, a US-based medical diagnostics technology spinout of Memorial Sloan Kettering Cancer Center, has secured $100m in a series C round co-led by medical products group Johnson & Johnson’s investment arm, Johnson & Johnson Innovation – JJDC.
Life sciences investment firm Casdin Capital co-led the round, which also featured undisclosed existing backers and investment funds. The company has now received a total of $195m since it was founded in 2017.
Paige is developing computational pathology technology in order…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?